XML 24 R13.htm IDEA: XBRL DOCUMENT v3.24.3
EQUITY
9 Months Ended
Sep. 30, 2024
Equity [Abstract]  
EQUITY

NOTE 5 – EQUITY:

 

a.

Private Placement

   
1.

On March 29, 2021, the Company issued to certain investors, including Moshe (Mori) Arkin, a major stockholder and director of the Company, an aggregate of 2,469,156 units in exchange for an aggregate purchase price of $20 million. Each such unit consisted of (i) one share of the Company’s common stock and (ii) one warrant to purchase one share of the Company’s common stock with an exercise price of $10.35 per share. Each such warrant is exercisable until March 31, 2026 and subject to customary adjustments. Pursuant to the terms of the foregoing warrants, following April 1, 2024, if the closing price of Company common stock equal or exceeds 135% of the aforementioned exercise price (subject to appropriate adjustments for stock splits, stock dividends, stock combinations and other similar transactions after the issue date of the warrants) for any thirty (30) consecutive trading days, the Company may force the exercise of the warrants, in whole or in part, by delivering to these investors a notice of forced exercise.

   
2. On March 16, 2023, the Company entered into stock purchase agreements for a private placement with (i) Moshe (Mori) Arkin and (ii) The Phoenix Insurance Company Ltd. (“Phoenix Insurance”) and Shotfut Menayot Israel – Phoenix Amitim (“Phoenix Amitim”), in connection with the sale and issuance of an aggregate of 3,294,117 units, at a purchase price of $4.25 per unit, and for an aggregate purchase price of $14 million. Each unit consisted of: (i) one share of the Company’s common stock and (ii) one warrant to purchase one share of the Company’s common stock with an exercise price of $5.50. The warrants are immediately exercisable, expire three years from the date of issuance and are subject to customary adjustments.
   
3.

On July 16, 2024, the Company issued 2,144,583 shares of its common stock in consideration for a purchase price of $4.80 per share to new and existing investors, including Moshe (Mori) Arkin and The Phoenix Holdings, through Phoenix Insurance and Phoenix Amitim (the “2024 Private Placement”). The Company raised approximately $10.3 million (gross) in the 2024 Private Placement.

 

Warrants:

 

As of September 30, 2024, the Company had the following outstanding warrants to purchase common stock:

 

         Exercise Price   Number of 
   Issuance  Expiration  Per Share   Underlying 
Warrant  Date  Date  ($)   Common Stocks 
               
March 2021 Warrants  March 29, 2021  March 31, 2026   10.35    2,469,156 
March 2023 Warrants  March 27, 2023  March 26, 2026   5.50    3,294,117 
               5,763,273 

 

 

ODYSIGHT.AI INC. (Formerly known as ScoutCam Inc.)

 

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 5 – EQUITY (continued):

 

  b. Stock-based compensation to employees, directors and service providers:

 

In February 2020, the Company’s Board of Directors approved the 2020 Share Incentive Plan (the “2020 Plan”).

 

The 2020 Plan initially included a pool of 580,890 shares of common stock for grant to Company employees, consultants, directors and other service providers. On March 15, 2020, the Company’s Board of Directors approved an increase to the 2020 Plan’s option pool by an additional 64,099 shares of common stock. On June 22, 2020, the Company’s Board of Directors approved an increase to the 2020 Plan’s option pool by an additional 401,950 shares of common stock. During the second quarter of 2021, the Company’s Board of Directors approved an increase to the 2020 Plan’s option pool by an additional 777,778 shares of common stock. During the first quarter of 2023, the Company’s Board of Directors approved an increase to the 2020 Plan’s option pool by an additional 1,000,000 shares of common stock.

 

In June 2024, the Company’s Board of Directors approved the 2024 Share Incentive Plan (the “2024 Plan”).

 

The 2024 Plan initially included a pool of 234,484 shares of common stock, representing the number of shares remaining available for grant under the 2020 Plan. These shares are available for future grant to Company employees, consultants, directors and other service providers. Shares that were subject to awards granted under either the 2020 Plan or the 2024 Plan that have expired or were cancelled or become un-exercisable for any reason without having been exercised in full shall become available for future grant under the 2024 Plan.

 

In July, 2024, the Company’s Board of Directors approved an increase to the 2024 Plan’s option pool by an additional 850,000 shares of common stock.

 

The 2020 Plan and 2024 Plan each provide for the grant of stock options (including incentive stock options and nonqualified stock options), shares of common stock, restricted shares, restricted share units, and other share-based awards.

 

Stock option activity:

 

During nine months ended September 30, 2024, the Company granted 91,000 options pursuant to the 2020 Plan and 669,500 options pursuant to the 2024 Plan.

 

The fair value of each option was estimated as of the date of grant or reporting period using the Black-Scholes option-pricing model, using the following assumptions:

 

   Nine months ended 
   September 30, 2024 
Underlying value of ordinary shares ($)   5.55-5.70 
Exercise price ($)   4.5-4.8 
Expected volatility (%)   101%
Term of the options (years)   7 
Risk-free interest rate   3.51%-4.23%

 

The cost of the benefit embodied in the options granted during the nine months ended September 30, 2024, based on their fair value as of the grant date, is estimated to be approximately $3,692 thousand. These amounts will be recognized in the statements of operations and comprehensive income over the vesting period.

 

The following table summarizes stock option activity for the nine months ended September 30, 2024:

 

   For the 
   Nine months ended 
   September 30, 2024 
       Weighted 
       average 
   Number of   exercise 
   Options   price 
         $ 
Outstanding at beginning of period   2,455,069    3.46 
Granted   760,500    4.76 
Forfeited   (23,335)   3 
Outstanding at end of period   3,192,234    3.77 
           
Vested at end of period   1,573,336    3.47 

 

 

ODYSIGHT.AI INC. (Formerly known as ScoutCam Inc.)

 

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 5 – EQUITY (continued):

 

Restricted stock unit (“RSU”) activity

 

The Company from time to time has granted RSUs to its employees and service provider pursuant to the 2020 Plan.

 

Each RSU will vest based on continued service which is generally over three years. The grant date fair value of the award will be recognized as stock-based compensation expense over the requisite service period. The fair value of restricted stock units was estimated on the date of grant based on the fair value of the Company’s common stock.

 

The following table summarizes RSU activity for the nine months ended September 30, 2024:

 

   For the 
   Nine months ended 
   September 30, 2024 
       Weighted Average 
   Number of   Grant Date Fair Value 
   RSUs   per Share 
         $ 
Outstanding at beginning of period   39,585    4.08 
Granted   -    - 
Forfeited   -    - 
Vested   (19,165)   4.34 
Unvested and Outstanding at end of period   20,420    3.84 

 

The following table sets forth the total stock-based payment expenses resulting from options and RSUs granted, included in the statements of operation and comprehensive income:

 

   2024   2023   2024   2023 
  

Nine months ended

September 30,

  

Three months ended

September 30,

 
   2024   2023   2024   2023 
   Unaudited 
   USD in thousands 
                 
Cost of revenues   23    11    6    6 
Research and development   402    323    177    58 
Sales and marketing expenses   151    83    56    21 
General and administrative   924    639    298    286 
Total expenses   1,500    1,056    537    371 

 

 

ODYSIGHT.AI INC. (Formerly known as ScoutCam Inc.)

 

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS